APA

Allred D. C., Clark G. M., Tandon A. K., Molina R., Tormey D. C., Osborne C. K., Gilchrist K. W., Mansour E. G., Abeloff M. & Eudey L. (19920423). HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Allred D C, Clark G M, Tandon A K, Molina R, Tormey D C, Osborne C K, Gilchrist K W, Mansour E G, Abeloff M and Eudey L. 19920423. HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Allred D. C., Clark G. M., Tandon A. K., Molina R., Tormey D. C., Osborne C. K., Gilchrist K. W., Mansour E. G., Abeloff M. and Eudey L. (19920423). HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Allred D C, Clark G M, Tandon A K, Molina R, Tormey D C, Osborne C K, Gilchrist K W, Mansour E G, Abeloff M and Eudey L. HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19920423.